Mitsubishi UFJ Asset Management
VIR icon

Mitsubishi UFJ Asset Management’s Vir Biotechnology VIR Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Sell
26,254
-16,436
-39% -$156K ﹤0.01% 983
2026
Q1 		$383K Sell
42,690
-1,055
-2% -$8.41K ﹤0.01% 895
2025
Q4 		$260K Sell
43,745
-6,264
-13% -$37.3K ﹤0.01% 977
2025
Q3 		$286K Buy
50,009
+99
+0.2% +$506 ﹤0.01% 951
2025
Q2 		$252K Buy
49,910
+11,620
+30% +$62.3K ﹤0.01% 947
2025
Q1 		$248K Buy
38,290
+3,209
+9% +$28.5K ﹤0.01% 936
2024
Q4 		$263K Buy
35,081
+9,311
+36% +$73.4K ﹤0.01% 946
2024
Q3 		$193K Sell
25,770
-2,430
-9% -$21.1K ﹤0.01% 970
2024
Q2 		$251K Buy
28,200
+4,221
+18% +$40.5K ﹤0.01% 936
2024
Q1 		$243K Sell
23,979
-1,099
-4% -$11.2K ﹤0.01% 941
2023
Q4 		$253K Buy
25,078
+14,271
+132% +$130K ﹤0.01% 986
2023
Q3 		$101K Hold
10,807
– – ﹤0.01% 1084
2023
Q2 		$265K Buy
10,807
+857
+9% +$21.5K ﹤0.01% 1002
2023
Q1 		$232K Buy
9,950
+648
+7% +$16.6K ﹤0.01% 1010
2022
Q4 		$232K Sell
9,302
-641
-6% -$15.7K ﹤0.01% 1007
2022
Q3 		$192K Hold
9,943
– – ﹤0.01% 1028
2022
Q2 		$253K Sell
9,943
-40
-0.4% -$934 ﹤0.01% 1016
2022
Q1 		$257K Buy
9,983
+635
+7% +$18.8K ﹤0.01% 1022
2021
Q4 		$368K Buy
9,348
+2,383
+34% +$93.4K ﹤0.01% 988
2021
Q3 		$303K Buy
6,965
+184
+3% +$7.97K ﹤0.01% 1010
2021
Q2 		$321K Sell
6,781
-6,515
-49% -$296K ﹤0.01% 1030
2021
Q1 		$682K Buy
13,296
+4,497
+51% +$242K ﹤0.01% 843
2020
Q4 		$236K Buy
+8,799
New +$286K ﹤0.01% 936

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mitsubishi UFJ Asset Management's VIR Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management reduced its Vir Biotechnology (VIR) stake by 39% in Q2 2026, selling an estimated $156K and leaving 26,254 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #983.

Mitsubishi UFJ Asset Management first reported a position in VIR in Q4 2020 and has held it in 23 quarters since. The position peaked at $682K in Q1 2021. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 26,254 shares of Vir Biotechnology worth $268K as of Q2 2026.
  • Mitsubishi UFJ Asset Management sold 16,436 Vir Biotechnology shares in Q2 2026, an estimated $156K.
  • Vir Biotechnology made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #983 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Vir Biotechnology in Q4 2020 and has held it in 23 quarters since.
  • Mitsubishi UFJ Asset Management's Vir Biotechnology position peaked at $682K in Q1 2021.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.